Ovensa Announces Collaboration with Tetra Bio-Pharma to Tackle Brain Cancer
Ovensa announced that it has entered into a collaboration agreement with Tetra Bio-Pharma to evaluate TRIOZAN™, a proprietary nanomedicine platform for targeted delivery of cannabinoids to brain tumor cells.